M12
Conditions
Interventions
Group 1: The clinical symptoms of the patients are evaluated according to the course of the file, as well as local imaging (MRI) at the same intervals as during the clinical check-ups.
Sponsors
LMU Klinikum
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients with a tenosynovial giant cell tumour who undergo surgery at the study centre during the study period will be included.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Local recurrence rate or progression of the disease. This is determined at the time of the final study evaluation using the last available MRI. | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival | — |
Countries
Germany
Contacts
Public ContactHans Roland Dürr
LMU Klinikum
Outcome results
None listed